Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Pharmacology

• Publication date

  1999-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0702926PMID 10578149PMCID PMC1571760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting response: noradrenaline reuptake inhibition.

  1999cited by this paper
• Somatodendritic α2‐Adrenoceptors in the Locus Coeruleus Are Involved in the In Vivo Modulation of Cortical Noradrenaline Release by the Antidepressant Desipramine

  1998cited by this paper
• Preferential Potentiation of the Effects of Serotonin Uptake Inhibitors by 5‐HT1A Receptor Antagonists in the Dorsal Raphe Pathway: Role of Somatodendritic Autoreceptors

  1997cited by this paper
• Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.

  1997cited by this paper
• Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

  1996cited by this paper
• The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

  1996cited by this paper
• Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.

  1996cited by this paper
• Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding

  1995cited by this paper
• Stereoselective and species-dependent kinetics of reboxetine in mouse and rat.

  1995cited by this paper
• Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors.

  1994cited by this paper
• Focal and systemic cocaine differentially affect extracellular norepinephrine in the locus coeruleus, frontal cortex and hippocampus of the anaesthetized rat.

  1994cited by this paper
• Regional differences in the in vivo regulation of the extracellular levels of noradrenaline and its metabolites in rat brain.

  1994cited by this paper
• Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.

  1994cited by this paper
• Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.

  1994cited by this paper
• Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes.

  1992cited by this paper
• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

  1992cited by this paper
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

  1991cited by this paper
• Phosphinic acid analogues of GABA are antagonists at the GABAB receptor in the rat anococcygeus

  1991cited by this paper
• Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride.

  1991cited by this paper
• Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.

  1991cited by this paper
• Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies

  1989influential reference
• Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

  1988cited by this paper
• Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain.

  1985cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983influential reference
• Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.

  1980cited by this paper
• AChE-stained horizontal sections of the rat brain in stereotaxic coordinates.

  1980cited by this paper
• The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method.

  1974cited by this paper

• Neuron-astrocyte coupling in lateral habenula mediates depressive-like behaviors.

  2025cites this paper
• AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole

  2024cites this paper
• Role of central serotonin and noradrenaline interactions in the antidepressants' action: Electrophysiological and neurochemical evidence.

  2021cites this paper
• Noradrenergic profile of hippocampal formation theta rhythm in anaesthetized rats.

  2021cites this paper
• Effects of locus coeruleus activation and inactivation on hippocampal formation theta rhythm in anesthetized rats.

  2020cites this paper
• Investigating the Potential Role of Serotonin-2B Receptor Antagonism in the Neuronal Actions of Adjunctive Aripiprazole

  2020cites this paper
• Antidepressant-like effect of vitamin B6 in mice forced swimming test and the possible involvement of the noradrenergic system

  2019cites this paper
• Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers

  2018cites this paper
• Noradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia

  2018cites this paper
• Anne Vuorenpää: CELLULAR REGULATION OF THE NOREPINEPHRINE TRANSPORTER

  2018cites this paper
• The role of brain catecholamines in exercise-induced oculomotor fatigue

  2017cites this paper
• Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.

  2016cites this paper
• Predictive validity of the neurokinin-1 knockout mouse in research into Attention Deficit Hyperactivity Disorder

  2015cites this paper
• The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression

  2015cites this paper
• Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

  2014cites this paper
• The cardiovascular regulatory role of 5-HT in the nucleus tractus solitarius

  2014cites this paper
• Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum.

  2014cites this paper
• L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.

  2013cites this paper
• PATHOPHYSIOLOGY OF MOOD DISORDERS: NORADRENERGIC MECHANISMS

  2013cites this paper
• Monitoring Extracellular Monoamines with In Vivo Microdialysis in Awake Rats: A Practical Approach

  2013cites this paper
• Utility of Combined Treatment with Antipsychotic and Antidepressant Drugs: Scientific Rationales and Clinical Implications

  2013cites this paper
• Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.

  2012cites this paper
• Antidepressants are neuroprotective against nutrient deprivation stress in rat hippocampal neurons

  2012cites this paper
• Effets antalgiques des antidépresseurs monoaminergiques : de la dépression à la neuropathie : approche préclinique

  2012cites this paper
• Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through β2 receptor.

  2012cites this paper
• Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex

  2011cites this paper
• Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)

  2011cites this paper
• Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging

  2011influential citation
• Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.

  2011cites this paper
• Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex.

  2010influential citation
• A highly sensitive HPLC method with automated on-line sample pre-treatment and fluorescence detection for determination of reboxetine in human plasma.

  2010cites this paper
• Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

  2010cites this paper
• In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.

  2010cites this paper
• Noradrenaline acting at central b-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain : Implications for neurodegeneration

  2010cites this paper
• Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation.

  2010cites this paper
• Brain norepinephrine system as a target for antidepressant and mood stabilizing medications.

  2009cites this paper
• Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study

  2009cites this paper
• Nicotinic receptor-based therapeutics and candidates for smoking cessation.

  2009cites this paper
• Running exercise‐induced up‐regulation of hippocampal brain‐derived neurotrophic factor is CREB‐dependent

  2009cites this paper
• Noradrenergic neuromodulation of human attention for emotional and neutral stimuli

  2007cites this paper
• Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.

  2007cites this paper
• Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.

  2007cites this paper
• Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.

  2007cites this paper
• Anatomical Characteristics of Norepinephrine Axons in the Prefrontal Cortex: Unexpected Findings That May Indicate Low Activity State in Naïve Animals

  2007cites this paper
• Brain Norepinephrine: The locus coeruleus and regulation of behavioral flexibility and attention: clinical implications

  2007cites this paper
• Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing.

  2006cites this paper
• Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

  2006cites this paper
• Chapter 6.3 The use of brain microdialysis in antidepressant drug research

  2006cites this paper
• BEHAVIOURAL AND PHARMACOLOGICAL VALIDATION OF CHRONIC SOCIAL STRESS AS A MODEL OF DEPRESSIVE-LIKE SYMPTOMS IN RATS

  2006cites this paper
• Idazoxan increases perforant path-evoked EPSP slope paired pulse inhibition and reduces perforant path-evoked population spike paired pulse facilitation in rat dentate gyrus.

  2006cites this paper
• The promises and pitfalls of reboxetine.

  2006influential citation
• Molecular microfluorometry: converting arbitrary fluorescence units into absolute molecular concentrations to study binding kinetics and stoichiometry in transporters.

  2006cites this paper
• The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.

  2006influential citation
• PET imaging of norepinephrine transporters.

  2006cites this paper
• Investigation of a role for noradrenaline in the neurochemical and behavioural effects of an established and putative target for antianxiety/antidepressant drugs: a microdialysis and behavioural study in rats and NK1 receptor knockout mice.

  2005cites this paper
• Substrate Binding Stoichiometry and Kinetics of the Norepinephrine Transporter*

  2005cites this paper
• Chronic Reboxetine Desensitizes Terminal but not Somatodendritic α2-Adrenoceptors Controlling Noradrenaline Release in the Rat Dorsal Hippocampus

  2005influential citation
• Idazoxan activates rat forebrain glycogen phosphorylase in vivo: a histochemical study.

  2005cites this paper
• Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia

  2005cites this paper
• Very early treatment with fluoxetine and reboxetine causing long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of rats

  2005influential citation
• Untersuchungen zur differenziellen Genexpression im ZNS von Noradrenalintransporter-Knockout- und Wildtyp-Mäusen

  2005cites this paper
• Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain

  2004influential citation
• Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices.

  2004cites this paper
• Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine

  2004cites this paper
• Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies

  2004cites this paper
• Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations

  2004cites this paper
• The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus

  2004cites this paper
• The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.

  2004cites this paper
• Die klinische Besserungsrate unter Antidepressivatherapie

  2004cites this paper
• IMPACT OF LONG-TERM ANTIDEPRES- SANT TREATMENT ON CHRONIC STRESS INDUCED REDUCTION OF NEUROGENESIS IN ADULT RATS: REVELATIONS OF SEX/DRUG SPECIFIC REGULATION

  2004cites this paper
• High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.

  2004cites this paper
• Autoreceptor‐mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment

  2004cites this paper
• New approaches to developing antidepressants by enhancing monoaminergic neurotransmission

  2003cites this paper
• Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of alpha 2 and 5-HT1A receptors.

  2003cites this paper
• Modulation of frequency and duration of repetitive magnetic stimulation affects catecholamine levels and tyrosine hydroxylase activity in human neuroblastoma cells: implication for the antidepressant effect of rTMS.

  2003cites this paper
• Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine.

  2003cites this paper
• Norepinephrine but not Serotonin Reuptake Inhibitors Enhance Theta and Gamma Activity of the Septo-Hippocampal System

  2003cites this paper
• Noradrenaline in mood and anxiety disorders: basic and clinical studies

  2003cites this paper
• The efficacy of reboxetine in preventing and reverting a condition of escape deficit in rats.

  2003cites this paper
• Novel objects in a holeboard probe the role of the locus coeruleus in curiosity: support for two modes of attention in the rat.

  2003cites this paper
• Discriminative stimulus properties of antidepressant agents: a review

  2003cites this paper
• A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters

  2003cites this paper
• Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons.

  2003cites this paper
• Exploring effects of stress from a cellular and molecular perspective: gender-related dimorphisms and implications for pharmacotherapy

  2003cites this paper
• Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of α2 and 5-HT1A receptors

  2003cites this paper
• Regulatory Effects of Reboxetine Treatment Alone, or Following Paroxetine Treatment, on Brain Noradrenergic and Serotonergic Systems

  2003cites this paper
• Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo

  2003cites this paper
• Noradrenaline Reuptake Inhibition Enhances the Antipsychotic-like Effect of Raclopride and Potentiates D2-blockage–induced Dopamine Release in the Medial Prefrontal Cortex of the Rat

  2002cites this paper
• No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists.

  2002cites this paper
• Effects of Acute and Chronic Reboxetine Treatment on Stress-induced Monoamine Efflux in the Rat Frontal Cortex

  2002cites this paper
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

  2002cites this paper
• Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods.

  2002cites this paper
• Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action

  2002cites this paper
• Reboxetine: attenuation of intravenous nicotine self-administration in rats.

  2002cites this paper
• Imidazoline antihypertensive drugs: a critical review on their mechanism of action.

  2002cites this paper
• Noradrenalin-selektive Antdeessva(NRI)

  2002cites this paper
• A Proximal Promoter Domain Containing a Homeodomain-Binding Core Motif Interacts with Multiple Transcription Factors, Including HoxA5 and Phox2 Proteins, and Critically Regulates Cell Type-Specific Transcription of the Human Norepinephrine Transporter Gene

  2002cites this paper
• Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons

  2002cites this paper
• Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats

  2001influential citation
• Response of the Norepinephrine System to Antidepressant Drugs

  2001cites this paper